These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26499223)

  • 1. Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial.
    Thomas M; Nienaber CA; Ince H; Erglis A; Vukcevic V; Schäfer U; Ferreira RC; Hardt S; Verheye S; Gama Ribeiro V; Sugeng L; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):710-7. PubMed ID: 26499223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.
    Costa MA; Mazzaferri EL; Sievert H; Abraham WT
    Circ Heart Fail; 2014 Sep; 7(5):752-8. PubMed ID: 25037310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PARACHUTE IV trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles.
    Costa MA; Pencina M; Nikolic S; Engels T; Templin B; Abraham WT
    Am Heart J; 2013 Apr; 165(4):531-6. PubMed ID: 23537969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study.
    Yang YJ; Huo Y; Xu YW; Wang JA; Han YL; Ge JB; Zhang RY; Yan XY; Gao RL
    Chin Med J (Engl); 2016 Sep; 129(17):2058-62. PubMed ID: 27569231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial.
    Mazzaferri EL; Gradinac S; Sagic D; Otasevic P; Hasan AK; Goff TL; Sievert H; Wunderlich N; Nikolic SD; Abraham WT
    Am Heart J; 2012 May; 163(5):812-820.e1. PubMed ID: 22607859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in patient selection for the parachute device implantation.
    Bozdag-Turan I; Bermaoui B; Paranskaya L; GökmenTuran R; D'Ancona G; Kische S; Birkemeyer R; Jovanovic B; Schuetz J; Akin I; Turan CH; Ortak J; Hauenstein K; Nienaber CA; Ince H
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E718-25. PubMed ID: 23592588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac computed tomography assessment of the near term impact of percutaneous ventricular restoration therapy (parachute(®) ) on mitral valve geometry.
    Tam CC; Fares A; Alaiti A; Shaikh K; Ince H; Erglis A; Bezerra HG; Abraham WT; Costa MA; Attizzani GF
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E45-51. PubMed ID: 26526037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognosis analysis of PARACHUTE device implantation in patients with ischemic heart failure: a single-center experience of Chinese patients.
    Li J; Liu H; Liu Q; Liu C; Xiong W; Ma W; Zhang B; Dong S; Li T
    J Cardiothorac Surg; 2021 Apr; 16(1):98. PubMed ID: 33879206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial catheter-based ventricular reconstruction: a novel therapy for ischaemic heart failure with anteroapical aneurysm.
    Cheng Y; Aboodi MS; Wechsler AS; Kaluza GL; Granada JF; Van Bladel K; Annest LS; Yi GH
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):915-22. PubMed ID: 23985410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-man study of Heartech® percutaneous left ventricular partitioning device for treatment of heart failure postmyocardial infarction.
    Zhu Z; Yu J; Xu K; Tang Y; Fang Y; Gu J; Gu S; Ding F; Modine T; Zhang R
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):845-853. PubMed ID: 31231944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device.
    Klodell CT; Aranda JM; McGiffin DC; Rayburn BK; Sun B; Abraham WT; Pae WE; Boehmer JP; Klein H; Huth C
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):188-95. PubMed ID: 18179940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.
    Bozdag-Turan I; Paranskaya L; Birkemeyer R; Turan RG; Kische S; Akin I; Ortak J; Stoeckicht Y; Schubert J; Westphal B; Nienaber CA; Ince H
    Cardiovasc Ther; 2014 Apr; 32(2):66-73. PubMed ID: 24354948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial.
    Costanzo MR; Ivanhoe RJ; Kao A; Anand IS; Bank A; Boehmer J; Demarco T; Hergert CM; Holcomb RG; Maybaum S; Sun B; Vassiliades TA; Rayburn BK; Abraham WT
    J Card Fail; 2012 Jun; 18(6):446-58. PubMed ID: 22633302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
    Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
    Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
    EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.